SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-018059
Filing Date
2022-10-03
Accepted
2022-10-03 16:55:54
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4084
  Complete submission text file 0001567619-22-018059.txt   5669
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROCESSA PHARMACEUTICALS, INC. 7300 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076
Business Address
Floyd Robert Michael (Reporting) CIK: 0001828217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 221288191